Rh 血型不相容

Brennand J, Cameron A. Fetal anaemia: diagnosis and management. Best Pract Res Clin Obstet Gynaecol. 2008 Feb;22(1):15-29.

• 摘要

Fung Kee Fung K, Eason E, Crane J, et al. Prevention of Rh alloimmunization. J Obstet Gynaecol Can. 2003 Sep;25(9):765-73.

• 全文
• 摘要

Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med. 2000 Jan 6;342(1):9-14.

• 全文
• 摘要

McBain RD, Crowther CA, Middleton P. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev. 2015 Sep 3;(9):CD000020.

• 全文
• 摘要

Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al; LOTUS study group. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol. 2012 Feb;206(2):141.e1-8.

• 全文
• 摘要

1.  Hadley AG. In vitro assays to predict the severity of hemolytic disease of the newborn. Transfus Med Rev. 1995 Oct;9(4):302-13.

• 摘要

2.  Bromilow IM, Downing I, Walkinshaw SA, et al. A case of unexplained mild Rh (D) haemolytic disease in utero. Transfus Med. 1995 Mar;5(1):31-5.

• 摘要

3.  Brennand J, Cameron A. Fetal anaemia: diagnosis and management. Best Pract Res Clin Obstet Gynaecol. 2008 Feb;22(1):15-29.

• 摘要

4.  Mourant AE, Kopec AC, Domaniewska-Sobczak K. The distribution of the human blood groups and other biochemical polymorphisms. 2nd ed. London: Oxford University Press; 1976.

5.  Joseph KS, Kramer MS. The decline in Rh hemolytic disease: should Rh prophylaxis get all the credit? Am J Public Health. 1998 Feb;88(2):209-15.

• 全文
• 摘要

6.  Van der Schoot CE, Soussan AA, Koelewijn J, et al. Non-invasive antenatal RHD typing. Transfus Clin Biol. 2006 Mar-Apr;13(1-2):53-7.

• 摘要

7.  National Institute for Health and Care Excellence. Routine antenatal anti-D prophylaxis for women who are rhesus D negative. Aug 2008 [internet publication].

• 全文

8.  Chavez GF, Mulinare J, Edmonds LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA. 1991 Jun 26;265(24):3270-4.

• 摘要

9.  Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2003. Natl Vital Stat Rep. 2005 Sep 8;54(2):1-116.

• 全文
• 摘要

10.  Koelewijn JM, Vrijkotte TG, van der Schoot CE, et al. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008 May;48(5):941-52.

• 摘要

11.  Cherif-Zahar B, Mattei MG, Le Van Kim C, et al. Localization of the human Rh blood group gene structure to chromosome region 1p34.3-1p36.1 by in situ hybridization. Hum Genet. 1991 Feb;86(4):398-400.

• 摘要

12.  Moise KJ. Red blood cell alloimmunization in pregnancy. Semin Hematol. 2005 Jul;42(3):169-78.

• 摘要

13.  Bowman JM, Pollock JM, Penston LE. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang. 1986;51(2):117-21.

• 摘要

14.  Bowman JM. The prevention of Rh immunization. Transfus Med Rev. 1988 Sep;2(3):129-50.

• 摘要

15.  Bowman JM. The management of Rh-Isoimmunization. Obstet Gynecol. 1978 Jul;52(1):1-16.

• 摘要

16.  Fung Kee Fung K, Eason E, Crane J, et al. Prevention of Rh alloimmunization. J Obstet Gynaecol Can. 2003 Sep;25(9):765-73.

• 全文
• 摘要

17.  Urbaniak SJ, Greiss MA. RhD haemolytic disease of the fetus and the newborn. Blood Rev. 2000 Mar;14(1):44-61.

• 摘要

18.  Moise KJ Jr. Hemolytic disease of the fetus and newborn. In: Creasy RK, Resnik R, Iams JD, et al, eds. Creasy and Resnik's maternal-fetal medicine: principles and practice. 6th ed. Philadelphia, PA: Saunders; 2008:479-503.

19.  Oepkes D, Adama van Scheltema P. Intrauterine fetal transfusion in the management of fetal anemia and fetal thrombocytopenia. Semin Fetal Neonatal Med. 2007 Dec;12(6):432-8.

• 摘要

20.  Grootscholten K, Kok M, Oei SG, et al. External cephalic version-related risks: a meta-analysis. Obstet Gynecol. 2008 Nov;112(5):1143-51.

• 摘要

21.  Katz J, Marcus RG. The risk of Rh isoimmunization in ruptured tubal pregnancy. Br Med J. 1972 Sep 16;3(5828):667-9.

• 全文
• 摘要

22.  Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med. 2000 Jan 6;342(1):9-14.

• 全文
• 摘要

23.  McBain RD, Crowther CA, Middleton P. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev. 2015 Sep 3;(9):CD000020.

• 全文
• 摘要

24.  Lee D, Rawlinson VI. Multicentre trial of antepartum low-dose anti-D immunoglobulin. Transfus Med. 1995 Mar;5(1):15-9.

• 摘要

25.  Chitty LS, Finning K, Wade A, et al. Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study. BMJ. 2014 Sep 4;349:g5243.

• 全文
• 摘要

26.  Qureshi H, Massey E, Kirwan D, et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014 Feb;24(1):8-20.

• 全文
• 摘要

27.  National Institute for Health and Care Excellence. High-throughput non-invasive prenatal testing for fetal RHD genotype. Nov 2016 [internet publication].

• 全文

28.  Bowman JM. Intrauterine and neonatal transfusion. In: Anderson KC, Ness PM, eds. Scientific basis of transfusion medicine: implications for clinical practice. London, UK: WB Saunders; 1994:403-20.

29.  Abdel-Fattah S, Soothill P. Assessing the severity of haemolytic disease of the fetus and newborn: clinical aspects. In: Hadley A, Soothill P, eds. Alloimmune disorders of pregnancy: anaemia, thrombocytopenia and neutropenia in the fetus and newborn. Cambridge, UK: Cambridge University Press; 2002:153-72.

30.  Bellini C, Hennekam RC, Bonioli E. A diagnostic flow chart for non-immune hydrops fetalis. Am J Med Gen A. 2009 May;149A(5):852-3.

• 摘要

31.  Trainor B, Tubman R. The emerging pattern of hydrops fetalis: incidence, aetiology and management. Ulster Med J. 2006 Sep;75(3):185-6.

• 全文
• 摘要

32.  Suwanrath-Kengpol C, Kor-anantakul O, Suntharasaj T, et al. Etiology and outcome of non-immune hydrops fetalis in southern Thailand. Gynecol Obstet Invest. 2005;59(3):134-7.

• 摘要

33.  Tolfvenstam T, Broliden K. Parvovirus B19 infection. Semin Fetal Neonatal Med. 2009 Aug;14(4):218-21.

• 摘要

34.  Hamill N, Rijhsinghani A, Williamson RA, et al. Prenatal diagnosis and management of fetal anemia secondary to a large chorioangioma. Obstet Gynecol. 2003 Nov;102(5 Pt 2):1185-8.

• 摘要

35.  El Kateb A, Ville Y. Update on twin-to-twin transfusion syndrome. Best Pract Res Clin Obstet Gynaecol. 2008 Feb;22(1):63-75.

• 摘要

36.  Baschat AA, Oepkes D. Twin anemia-polycythemia sequence in monochorionic twins: implications for diagnosis and treatment. Am J Perinatol. 2014 Sep;31(suppl 1):S25-30.

• 摘要

37.  Okwundu CI, Afolabi BB. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD007885.

• 全文
• 摘要

38.  Li MJ, Chen CH, Wu Q, et al. Intravenous immunoglobulin G for hemolytic disease of the newborn: a systematic review [in Chinese]. Chin J Evid Based Med. 2010;10:1199-204.

• 全文

39.  Huizing K, Røislien J, Hansen T. Intravenous immunoglobulin reduces the need for exchange transfusion in Rhesus and ABO incompatibility. Acta Paediatr. 2008 Oct;97(10):1362-5.

• 摘要

40.  Smits-Wintjens VE, Walther FJ, Rath ME, et al. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. Pediatrics. 2011 Apr;127(4):680-6.

• 摘要

41.  Zwiers C, Scheffer-Rath ME, Lopriore E, et al. Immunoglobulin for alloimmune hemolytic disease in neonates. Cochrane Database Syst Rev. 2018 Mar 18;(3):CD003313.

• 全文
• 摘要

42.  Stephen J, Cairns LS, Pickford WJ, et al. Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K bloodgroup antigen. Blood. 2012 Jun 7;119(23):5563-74.

• 摘要

43.  Matsuda H, Yoshida M, Wakamatsu H, et al. Fetal intraperitoneal injection of immunoglobulin diminishes alloimmune hemolysis. J Perinatol. 2011 Apr;31(4):289-92.

• 摘要

44.  Bellone M, Boctor FN. Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion. Transfusion. 2014 Aug;54(8):2118-21.

• 摘要

45.  Kriplani A, Malhotra Singh B, Mandal K. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Gynecol Obstet Invest. 2007;63(3):176-80.

• 摘要

46.  Smits-Wintjens VE, Walther FJ, Lopriore E. Rhesus haemolytic disease of the newborn: postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med. 2008 Aug;13(4):265-71.

• 摘要

47.  Marton T, Cox PM. Fetal hydrops. In: Kurjak A, Chervenak FA, eds. Textbook of perinatal medicine. 2nd ed. Abingdon, UK: Informa UK; 2006:535-40.

48.  De Boer IP, Zeestraten EC, Lopriore E, et al. Pediatric outcome in rhesus hemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol. 2008 Jan;198(1):54.e1-4.

• 摘要

49.  Weiner CP, Williamson RA, Wenstrom KD, et al. Management of fetal hemolytic disease by cordocentesis. I. Prediction of fetal anemia. Am J Obstet Gynecol. 1991 Sep;165(3):546-53.

• 摘要

50.  Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al; LOTUS study group. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol. 2012 Feb;206(2):141.e1-8.

• 全文
• 摘要